[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -29.20 -1.9% 1,510.80 1,510.60 1,511.00 1,526.80 1,503.00 1,512.00 9,429,888 16:29:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 16.1 76,009

GlaxoSmithKline, SK Bioscience Begin Phase 3 Trial of Covid-19 Vaccine

31/08/2021 7:50am

Dow Jones News


Glaxosmithkline (LSE:GSK)
Historical Stock Chart


From Aug 2021 to Nov 2021

Click Here for more Glaxosmithkline Charts.

By Adam Clark

 

GlaxoSmithKline PLC said Tuesday that it and South Korean company SK Bioscience Co Ltd. have started a Phase 3 trial of their Covid-19 vaccine combination.

The British pharmaceutical company said the advance follows positive immunogenicity and safety data from earlier trials and that the partners are aiming for a global supply of the vaccine via the Covax facility in the first half of 2022, subject to data and regulatory review.

The trial combines SK Bioscience's vaccine candidate with GSK's adjuvant, an ingredient used to prompt a stronger immune response.

The randomized trial will enroll around 4,000 participants and compare the vaccine against the AstraZeneca PLC vaccine, with data due in the first half of 2022.

 

Write to Adam Clark at adam.clark@wsj.com

 

(END) Dow Jones Newswires

August 31, 2021 02:35 ET (06:35 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Glaxosmithkline Chart

1 Year Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

1 Month Glaxosmithkline Chart
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211128 09:20:03